Illuminating Hope: How Light Therapy Can Transform the Lives of Children with Autism

Autism Spectrum Disorder (ASD)

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition marked by language delays, social-interaction difficulties, repetitive behaviors, and a range of cognitive challenges.

Light can strongly influence mood and behavior. Color tone and brightness affect most people, and individuals with autism may respond even more intensely.

Children with ASD often show heightened sensitivity to lighting. Soft hues such as pale blue can promote calm and creativity, whereas flickering, humming, or harsh lights may cause discomfort or agitation. Dimmable, quiet fixtures give caregivers better control over the sensory environment.

Natural light also matters. Reduced daylight in winter can contribute to seasonal affective disorder (SAD), sometimes worsening irritability or low mood. Access to daylight or a daylight-mimicking source may ease these effects.

Bright-light sessions may also help regulate circadian rhythms—the internal "clock" that governs sleep–wake cycles. A short morning session (starting with as little as 10–15 min and building up to about 30 min) can support easier sleep onset at night and greater daytime alertness. Evening exposure is usually discouraged because it might delay sleep.

This information is educational and not a substitute for professional medical advice.

Further reading:

• NICHD: Autism Spectrum Disorder overview
• PubMed search for light therapy and ASD
• Mayo Clinic: Seasonal affective disorder

Clinical Study

A study examined whether low-level laser therapy, a form of photobiomodulation, could ease irritability linked to autistic spectrum disorder in children and adolescents aged 5–17 years. Twenty-one of 40 participants received eight 5-min procedures at the base of the skull and temporal areas over 4 weeks (active group). All were assessed with the Aberrant Behavior Checklist (ABC)—global score and five subscales—and the Clinical Global Impressions (CGI) Scale at baseline, week 2, week 4, and week 8. The adjusted mean change in ABC irritability subscale from baseline to endpoint was –15.17 points greater in the active group (ANCOVA F = 99.34, p < 0.0001). The authors suggest low-level laser therapy may reduce irritability and related behaviors, with improvements persisting and slightly increasing after treatment ended.

Previous work indicates that low-level laser light can traverse the skull. The proposed mechanism involves quantum optical induced transparency, which may enhance light transmission through dense tissue, allowing non-invasive irradiation of deeper brain structures.

Conclusions

The data suggest photobiomodulation produced a statistically significant and clinically meaningful improvement in core autism-related behaviors in this cohort, with gains continuing for up to six months after the final session.

This information is educational and not a substitute for professional medical advice.

PubMed search

LLLT may produce a therapeutic effect by delivering non-ionizing light—such as lasers, light-emitting diodes, or broadband sources—in the visible red (600–700 nm) and near-infrared (780–1100 nm) ranges. This non-thermal process begins when chromophore molecules absorb light of the appropriate wavelength. Chromophores give color to compounds like hemoglobin, myoglobin, and cytochromes; after absorbing a photon, an electron moves to an excited state. The resulting physiologic changes appear to occur when photons displace the inhibitory signaling molecule nitric oxide (NO) from cytochrome c oxidase, which may increase electron transport, mitochondrial membrane potential, and the production of ATP, NADH, RNA, and other mitochondrial products. The leading hypothesis is that this release of NO from the enzyme enhances electron flow, mitochondrial membrane potential, and ATP synthesis.

References

1. Abbott, A. E., A. C. Linke, A. Nair, A. Jahedi, L. A. Alba, C. L. Keown, I. Fishman, and R. A. Muller. 2018. 'Repetitive behaviors in autism are linked to imbalance of corticostriatal connectivity: a functional connectivity MRI study', Soc Cogn Affect Neurosci, 13: 32-42.
2. Batista-Garcia-Ramo, K., and C. I. Fernandez-Verdecia. 2018. 'What we know about the brain structure–function relationship', Behav Sci (Basel), 8.
3. Brown, E. C., M. G. Aman, and S. M. Havercamp. 2002. 'Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education', Res Dev Disabil, 23: 45-60.
4. de Freitas, L. F., and M. R. Hamblin. 2016. 'Proposed mechanisms of photobiomodulation or low-level light therapy', IEEE J Sel Top Quantum Electron, 22.
5. Demirtas-Tatlidede, A., A. M. Vahabzadeh-Hagh, M. Bernabeu, J. M. Tormos, and A. Pascual-Leone. 2012. 'Noninvasive brain stimulation in traumatic brain injury', J Head Trauma Rehabil, 27: 274-92.
6. Emelyanov, A. N., and V. V. Kiryanova. 2015. 'Photomodulation of proliferation and differentiation of stem cells by the visible and infrared light', Photomed Laser Surg, 33: 164-74.
7. Freitas, L. F., M. R. Hamblin, F. Anzengruber, J. R. Perussi, A. O. Ribeiro, V. C. A. Martins, and A. M. G. Plepis. 2017. 'Zinc phthalocyanines attached to gold nanorods for simultaneous hyperthermic and photodynamic therapies against melanoma in vitro', J Photochem Photobiol B, 173: 181-86.
8. Hamblin, M. R. 2018. 'Photobiomodulation for traumatic brain injury and stroke', J Neurosci Res, 96: 731-43.
9. Heiskanen, V., and M. R. Hamblin. 2018. 'Photobiomodulation: lasers vs. light emitting diodes?', Photochem Photobiol Sci, 17: 1003-17.
10. Henderson, T. A., and L. D. Morries. 2015. 'Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain?', Neuropsychiatr Dis Treat, 11: 2191-208.
11. Hiwaki, O., and H. Miyaguchi. 2018. 'Noninvasive measurement of dynamic brain signals using light penetrating the brain', PLoS One, 13: e0192095.
12. Huang, Y. Y., A. Gupta, D. Vecchio, V. J. de Arce, S. F. Huang, W. Xuan, and M. R. Hamblin. 2012. 'Transcranial low level laser (light) therapy for traumatic brain injury', J Biophotonics, 5: 827-37.
13. Jiang, P., V. Vuontela, M. Tokariev, H. Lin, E. T. Aronen, Y. Ma, and S. Carlson. 2018. 'Functional connectivity of intrinsic cognitive networks during resting state and task performance in preadolescent children', PLoS One, 13: e0205690.
14. Kaat, A. J., L. Lecavalier, and M. G. Aman. 2014. 'Validity of the Aberrant Behavior Checklist in children with autism spectrum disorder', J Autism Dev Disord, 44: 1103-16.
15. Karabekiroglu, K., and M. G. Aman. 2009. 'Validity of the Aberrant Behavior Checklist in a clinical sample of toddlers', Child Psychiatry Hum Dev, 40: 99-110.
16. Khuman, J., J. Zhang, J. Park, J. D. Carroll, C. Donahue, and M. J. Whalen. 2012. 'Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice', J Neurotrauma, 29: 408-17.

Further reading: PubMed database

17. Kotkowski, E., L. R. Price, P. Mickle Fox, T. J. Vanasse, and P. T. Fox. 2018. 'The hippocampal network model: A transdiagnostic metaconnectomic approach', Neuroimage Clin, 18: 115-29.
18. Lapchak, P. A., and P. D. Boitano. 2016. 'Transcranial near-infrared laser therapy for stroke: How to recover from futility in the NEST-3 clinical trial', Acta Neurochir Suppl, 121: 7-12.
19. Leisman, G., C. Machado, Y. Machado, and M. Chinchilla-Acosta. 2018. 'Effects of low-level laser therapy in autism spectrum disorder', Adv Exp Med Biol.
20. Machado, C., M. Estevez, G. Leisman, R. Melillo, R. Rodriguez, P. DeFina, A. Hernandez, J. Perez-Nellar, R. Naranjo, M. Chinchilla, N. Garofalo, J. Vargas, and C. Beltran. 2015. 'QEEG spectral and coherence assessment of autistic children in three different experimental conditions', J Autism Dev Disord, 45: 406-24.
21. Machado, C., M. Estevez, R. Rodriguez, and G. Leisman. 2017. 'Letter re: The autism "epidemic": Ethical, legal, and social issues in a developmental spectrum disorder', Neurology, 89: 1310.
22. Machado, C. J., and J. Bachevalier. 2003. 'Non-human primate models of childhood psychopathology: The promise and the limitations', J Child Psychol Psychiatry, 44: 64-87.
23. Machado, C., R. Rodriguez, M. Estevez, G. Leisman, R. Melillo, M. Chinchilla, and L. Portela. 2015. 'Anatomic and functional connectivity relationship in autistic children during three different experimental conditions', Brain Connect, 5: 487-96.
24. Moreira, M. S., I. T. Velasco, L. S. Ferreira, S. K. Ariga, F. Abatepaulo, L. T. Grinberg, and M. M. Marques. 2011. 'Effect of laser phototherapy on wound healing following cerebral ischemia by cryogenic injury', J Photochem Photobiol B, 105: 207-15.
25. Morries, L. D., P. Cassano, and T. A. Henderson. 2015. 'Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy', Neuropsychiatr Dis Treat, 11: 2159-75.
26. Naeser, M. A., P. I. Martin, M. D. Ho, M. H. Krengel, Y. Bogdanova, J. A. Knight, M. K. Yee, R. Zafonte, J. Frazier, M. R. Hamblin, and B. B. Koo. 2016. 'Transcranial, red/near-infrared light-emitting diode therapy to improve cognition in chronic traumatic brain injury', Photomed Laser Surg, 34: 610-26.
27. Poiani, Gdcr, A. L. Zaninotto, A. M. C. Carneiro, R. A. Zangaro, A. S. I. Salgado, R. B. Parreira, A. F. de Andrade, M. J. Teixeira, and W. S. Paiva. 2018. 'Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: A randomized controlled trial study protocol', Trials, 19: 17.
28. Primo, F. L., M. B. da Costa Reis, M. A. Porcionatto, and A. C. Tedesco. 2011. 'In vitro evaluation of chloroaluminum phthalocyanine nanoemulsion and low-level laser therapy on human skin dermal equivalents and bone marrow mesenchymal stem cells', Curr Med Chem, 18: 3376-81.
29. Raj, A., and F. Powell. 2018. 'Models of network spread and network degeneration in brain disorders', Biol Psychiatry Cogn Neurosci Neuroimaging, 3: 788-97.
30. Ranasinghe, K. G., L. B. Hinkley, A. J. Beagle, D. Mizuiri, S. M. Honma, A. E. Welch, I. Hubbard, M. L. Mandelli, Z. A. Miller, C. Garrett, A. La, A. L. Boxer, J. F. Houde, B. L. Miller, K. A. Vossel, M. L. Gorno-Tempini, and S. S. Nagarajan. 2017. 'Distinct spatiotemporal patterns of neuronal functional connectivity in primary progressive aphasia variants', Brain, 140: 2737-51.
31. Rochkind, S., A. Shahar, M. Amon, and Z. Nevo. 2002. 'Transplantation of embryonal spinal cord nerve cells cultured on biodegradable microcarriers followed by low-power laser irradiation for the treatment of traumatic paraplegia in rats', Neurol Res, 24: 355-60.
32. Rojahn, J., and W. J. Helsel. 1991. 'The Aberrant Behavior Checklist with children and adolescents with dual diagnosis', J Autism Dev Disord, 21: 17-28.
33. Salehpour, F., J. Mahmoudi, F. Kamari, S. Sadigh-Eteghad, S. H. Rasta, and M. R. Hamblin. 2018. 'Brain Photobiomodulation Therapy: a Narrative Review', Mol Neurobiol, 55: 6601-36.
34. Scherman, M., O. S. Mishina, P. Lombardi, E. Giacobino, and J. Laurat. 2012. 'Enhancing electromagnetically induced transparency in a multilevel broadened medium', Opt Express, 20: 4346-51.
35. Shen, C. C., Y. C. Yang, T. B. Huang, S. C. Chan, and B. S. Liu. 2013. 'Neural regeneration in a novel nerve conduit across a large gap of the transected sciatic nerve in rats with low-level laser phototherapy', J Biomed Mater Res A, 101: 2763-77.
36. Shen, C. C., Y. C. Yang, and B. S. Liu. 2013. 'Effects of large-area irradiated laser phototherapy on peripheral nerve regeneration across a large gap in a biomaterial conduit', J Biomed Mater Res A, 101: 239-52.
37. Stevens, E. J., and D. R. Tomlinson. 1995. 'Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes', Br J Pharmacol, 115: 373-9.